Millennium Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33,000
Closed -$350K 7110
2022
Q4
$350K Hold
33,000
﹤0.01% 4981
2022
Q3
$332K Hold
33,000
﹤0.01% 5283
2022
Q2
$329K Hold
33,000
﹤0.01% 5292
2022
Q1
$327K Hold
33,000
﹤0.01% 5469
2021
Q4
$324K Buy
+33,000
New +$10.4K ﹤0.01% 5465

Millennium Management's DMAQR Position: Q1 2024 in Review

Millennium Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 33,000 shares — an estimated $9.9K sold.

Millennium Management first reported a position in DMAQR in Q1 2023 and held it in 4 quarters. The position peaked at $11.5K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • Millennium Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 33,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $9.9K.
  • Millennium Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q1 2023 and held it in 4 quarters.
  • Millennium Management's Deep Medicine Acquisition Corp. Rights position peaked at $11.5K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.